Cited by 717Pancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsPancreatitis Pathology and Treatment

The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.

Pancreatic Cancer

Open access

Maitra, Anirban, Hruban, Ralph H.·2008·Annual Review of Pathology: Mechanisms of Disease

DOI 10.1146/annurev.pathmechdis.3.121806.154305PMC PMC2666336

Open this paper in CoChat — free account

Abstract

The past two decades have witnessed an explosion in our understanding of pancreatic cancer, and it is now clear that pancreatic cancer is a disease of inherited (germ-line) and somatic gene mutations. The genes mutated in pancreatic cancer include KRAS2, p16/CDKN2A, TP53, and SMAD4/DPC4, and these are accompanied by a substantial compendium of genomic and transcriptomic alterations that facilitate cell cycle deregulation, cell survival, invasion, and metastases. Pancreatic cancers do not arise de novo, and three distinct precursor lesions have been identified. Experimental models of pancreatic cancer have been developed in genetically engineered mice, which recapitulate the multistep progression of the cognate human disease. Although the putative cell of origin for pancreatic cancer remains elusive, minor populations of cells with stem-like properties have been identified that appear responsible for tumor initiation, metastases, and resistance of pancreatic cancer to conventional therapies.

Integrity signals

Registry

Crossref · 10.1146/annurev.pathmechdis.3.121806.154305

Cites

185 of 185 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Retracted: Notch‐1 down‐regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells
Wang, Z., Zhang, Y., Banerjee, S., Li, Y., & Sarkar, F. H. (2006) · Cancer · doi:10.1002/cncr.21904 · Cited by 263
Retracted
Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
1969 Cancer Facts and Figures
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,811
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
Bonnet, D. A., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 7,197
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,517
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P. G., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,895
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783

Show all 185 references

Research works printed but not linked: 24

10.1001/jama.1995.03520440059037 · DOI
Goggins M, 1996, Cancer Res., 56, 5360
de vos tot Nederveen Cappel WH, 2003, Clin. Cancer Res., 9, 3598
Goggins M, 1998, Am. J. Pathol., 152, 1501
Hruban RH, 2006, Tumors of the Pancreas
Iacobuzio-Donahue CA, 2003, Cancer Res., 63, 8614
Argani P, 2001, Cancer Res., 61, 4320
Argani P, 2001, Clin. Cancer Res., 7, 3862
Moskaluk CA, 1997, Cancer Res., 57, 2140
Altomare DA, 2003, J. Cell Biochem., 88, 470
Schutte M, 1997, Cancer Res., 57, 3126
Redston MS, 1994, Cancer Res., 54, 3025
Wilentz RE, 2000, Cancer Res., 60, 2002
Schutte M, 1996, Cancer Res., 56, 2527
Goggins M, 1998, Cancer Res., 58, 5329
Sato N, 2003, Cancer Res., 63, 4158
Ryu B, 2002, Cancer Res., 62, 819
Deramaudt T, 2005, Biochim. Biophys. Acta, 1756, 97
Brembeck FH, 2003, Cancer Res., 63, 2005
Ryu B, 2002, Cancer Res., 62, 819
Zhou W, 1998, Cancer Epidemiol. Biomark. Prev., 7, 109
Yamada T, 1998, Clin. Cancer Res., 4, 1527
Yamamoto H, 2001, Cancer Res., 61, 3139
van der Heijden MS, 2003, Cancer Res., 63, 2585

Sorted by citations

Items 101–200 of 717

Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility
Knudsen, E. S., Balaji, U., Mannakee, B. K., Vail, P. J., Eslinger, C. R., Moxom, C., Mansour, J. C., & Witkiewicz, A. K. (2017) · Gut · doi:10.1136/gutjnl-2016-313133 · Cited by 101
Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines
Park, S. H., Sung, J. H., Kim, E. J., & Chung, N. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20144293 · Cited by 100
Oleanolic acid arrests cell cycle and induces apoptosis via ROS‐mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells
Wei, J., Liu, M., Liu, H., Wang, H., Wang, F., Zhang, Y., Han, L., & Lin, X. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2725 · Cited by 98
Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by 1H nuclear magnetic resonance-based metabonomic profiles
Zhang, L., Jin, H., Guo, X., Yang, Z., Zhao, L., Tang, S., Ping, M., Wu, K., Nie, Y., Pan, Y., et al. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.05.012 · Cited by 98
LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway
Zhang, M., Zhao, Y. C., Zhang, Y., Wang, D., Gu, S., Feng, W., Peng, W., Gong, A., & Xu, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.03.005 · Cited by 97
The glycosylation landscape of pancreatic cancer (Review)
Munkley, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.9885 · Cited by 96
GATA6 Activates Wnt Signaling in Pancreatic Cancer by Negatively Regulating the Wnt Antagonist Dickkopf-1
Zhong, Y., Wang, Z., Fu, B., Pan, F., Yachida, S., Dhara, M., Albesiano, E., Li, L., Naito, Y., Vilardell, F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022129 · Cited by 97
Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma
Brody, J. R., Costantino, C. L., Potoczek, M., Cozzitorto, J. A., McCue, P. A., Yeo, C. J., Hruban, R. H., & Witkiewicz, A. K. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.15 · Cited by 94
Self-citation
Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient Survival
Rachakonda, P. S., Bauer, A. S., Xie, H., Campa, D., Rizzato, C., Canzian, F., Beghelli, S., Greenhalf, W., Costello, E., Schanne, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060870 · Cited by 93
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
Yousef, A., Yousef, M., Chowdhury, S., Abdilleh, K., Knafl, M., Edelkamp, P., Alfaro-Munoz, K., Chacko, R., Peterson, J., Smaglo, B. G., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00505-0 · Cited by 93
Self-citation
BET Bromodomain Inhibitors Block Growth of Pancreatic Cancer Cells in Three-Dimensional Collagen
Sahai, V., Kumar, K., Knab, L. M., Chow, C. R., Raza, S. S., Bentrem, D. J., Ebine, K., & Munshi, H. G. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0925 · Cited by 98
Early onset pancreatic cancer: Risk factors, presentation and outcome
Piciucchi, M., Capurso, G., Valente, R., Larghi, A., Archibugi, L., Signoretti, M., Stigliano, S., Zerboni, G., Barucca, V., Torre, M. L., et al. (2015) · Pancreatology · doi:10.1016/j.pan.2015.01.013 · Cited by 92
Antithetical NFATc1–Sox2 and p53–miR200 signaling networks govern pancreatic cancer cell plasticity
Singh, S. K., Chen, N., Heßmann, E., Siveke, J. T., Lahmann, M., Singh, G., Völker, N., Vogt, S., Esposito, I., Schmidt, A., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201489574 · Cited by 95
CXCL12 Chemokine Expression Suppresses Human Pancreatic Cancer Growth and Metastasis
Roy, I., Zimmerman, N. P., Mackinnon, A. C., Tsai, S., Evans, D. B., & Dwinell, M. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090400 · Cited by 92
Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM)
Carter, H. K., Samayoa, J. A., Hruban, R. H., & Karchin, R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.6.12537 · Cited by 88
Self-citation
Treatment of Pancreatic Cancer Patient–Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin
Rajeshkumar, N. V., Yabuuchi, S., Pai, S. G., Oliveira, E. D., Kamphorst, J. J., Rabinowitz, J. D., Tejero, H., Al‐Shahrour, F., Hidalgo, M. M., Maitra, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1115 · Cited by 89
Self-citation
Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice
Selvanesan, B. C., Chandra, D., Quispe‐Tintaya, W., Jahangir, A., Patel, A. S., Meena, K., da Silva, R. A. A., Friedman, M., Gabor, L. R., Khouri, O. R., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abc1600 · Cited by 91
Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib
Walters, D. M., Lindberg, J. M., Adair, S. J., Newhook, T. E., Cowan, C., Stokes, J. B., Borgman, C. A., Stelow, E. B., Lowrey, B. T., Chopivsky, M. E., et al. (2013) · Neoplasia · doi:10.1593/neo.121712 · Cited by 87
Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4
Fu, Y., Liu, X., Chen, Q., Liu, T., Lu, C., Yu, J., Miao, Y., & Wei, J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0807-2 · Cited by 87
Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4
Catanzaro, J. M., Sheshadri, N., Pan, J.-A., Sun, Y., Shi, C., Li, J., Powers, S., Crawford, H. C., & Zong, W. (2014) · Nature Communications · doi:10.1038/ncomms4729 · Cited by 88
Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma
Neeße, A., Gress, T. M., Tuveson, D. A., Michl, P., & Krug, S. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s38111 · Cited by 87
The role of pancreatic stellate cells in pancreatic cancer
Moir, J. A. G., Mann, J., & White, S. A. (2015) · Surgical Oncology · doi:10.1016/j.suronc.2015.05.002 · Cited by 84
Recent advances in pancreatic cancer: biology, treatment, and prevention
Singh, D. K., Upadhyay, G., Srivastava, R. K., & Shankar, S. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.04.003 · Cited by 85
Telomerase Inhibitor Imetelstat (GRN163L) Limits the Lifespan of Human Pancreatic Cancer Cells
Burchett, K. M., Yan, Y., & Ouellette, M. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085155 · Cited by 84
Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells
Park, E. H., Kim, S., Jo, J. Y., Kim, S. J., Hwang, Y., Kim, J., Song, S. Y., Lee, D. K., & Koh, S. S. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs378 · Cited by 84
The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays
Tewari, N., Zaitoun, A. M., Arora, A., Madhusudan, S., Ilyas, M., & Lobo, D. N. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-436 · Cited by 83
Re‐adapting T cells for cancer therapy: from mouse models to clinical trials
Stromnes, I. M., Schmitt, T. M., Chapuis, A. G., Hingorani, S. R., & Greenberg, P. D. (2013) · Immunological Reviews · doi:10.1111/imr.12141 · Cited by 82
Tissue and Serum microRNAs in the KrasG12D Transgenic Animal Model and in Patients with Pancreatic Cancer
LaConti, J. J., Shivapurkar, N., Preet, A., Mays, A. D., Peran, I., Kim, S. E., Marshall, J. L., Riegel, A. T., & Wellstein, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020687 · Cited by 83
Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies
Roy, R., Zurakowski, D., Wischhusen, J., Frauenhoffer, C., Hooshmand, S. M., Kulke, M. H., & Moses, M. A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.462 · Cited by 82
Molecular pathways in pancreatic carcinogenesis
Macgregor‐Das, A. M., & Iacobuzio–Donahue, C. A. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23213 · Cited by 80
Evaluation of 22G fine-needle aspiration (FNA) versus fine-needle biopsy (FNB) for endoscopic ultrasound-guided sampling of pancreatic lesions: a prospective comparison study
Tian, L., Tang, A., Zhang, L., Liu, X., Li, J., Wang, F., Shen, S., & Wang, X. (2018) · Surgical Endoscopy · doi:10.1007/s00464-018-6075-6 · Cited by 80
Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer
Moir, J., White, S., French, J., Littler, P., & Manas, D. (2014) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2014.08.480 · Cited by 80
Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the Pancreas
Hidalgo, M. M., & Hoff, D. D. V. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1327 · Cited by 81
Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells
Takahashi, K., Ehata, S., Koinuma, D., Morishita, Y., Soda, M., Mano, H., & Miyazono, K. (2018) · Oncogene · doi:10.1038/s41388-018-0144-0 · Cited by 79
Targeting microRNAs in Pancreatic Cancer: Microplayers in the Big Game
Khan, S., Ansarullah, M., Kumar, D., Jaggi, M., & Chauhan, S. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1288 · Cited by 78
KLF4α Up-regulation Promotes Cell Cycle Progression and Reduces Survival Time of Patients With Pancreatic Cancer
Wei, D., Wang, L., Kanai, M., Jia, Z., Le, X., Li, Q., Wang, H., & Xie, K. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.022 · Cited by 78
Pathological and Molecular Evaluation of Pancreatic Neoplasms
Rishi, A., Goggins, M., Wood, L. D., & Hruban, R. H. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.004 · Cited by 79
Self-citation
Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer
Rucki, A. A., Foley, K., Zhang, P., Xiao, Q., Kleponis, J., Wu, A. A., Sharma, R. B., Mo, G., Liu, A., Eyk, J. E. V., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1383 · Cited by 77
Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers
Yue, T., Maupin, K. A., Fallon, B. P., Li, L., Partyka, K. A., Anderson, M. A., Brenner, D. E., Kaul, K. L., Zeh, H. J., Moser, A. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029180 · Cited by 76
Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2
Deeb, D., Gao, X., Liu, Y. B., Pindolia, K. R., & Gautam, S. C. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2325 · Cited by 75
Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
Inamura, K., Takazawa, Y., Inoue, Y., Yokouchi, Y., Kobayashi, M., Saiura, A., Shibutani, T., & Ishikawa, Y. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7070172 · Cited by 73
Presence of Pancreatic Intraepithelial Neoplasia in the Pancreatic Transection Margin does not Influence Outcome in Patients with R0 Resected Pancreatic Cancer
Matthaei, H., Hong, S., Mayo, S. C., Molin, M. D., Olino, K. L., Venkat, R., Goggins, M., Herman, J. M., Edil, B. H., Wolfgang, C. L., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1745-9 · Cited by 73
Self-citation
Apoptosis pathways and their therapeutic exploitation in pancreatic cancer
Fulda, S. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00748.x · Cited by 72
Immunotherapy in Gastrointestinal Cancers
Procaccio, L., Schirripa, M., Fassan, M., Vecchione, L., Bergamo, F., Prete, A. A., Intini, R., Manai, C., Dadduzio, V., Boscolo, A., et al. (2017) · BioMed Research International · doi:10.1155/2017/4346576 · Cited by 72
Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathwaysPreprint
Bhattacharyya, S., Pradhan, K., Campbell, N. R., Mazdo, J., Vasantkumar, A., Maqbool, S. B., Bhagat, T. D., Gupta, S., Suzuki, M., Yu, Y., et al. (2017) · Genome Research · doi:10.1101/gr.222794.117 · Cited by 74
Self-citation
Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1
Kent, O. A., Mendell, J. T., & Rottapel, R. K. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0456 · Cited by 71
Molecular Imaging of Pancreatic Cancer with Antibodies
England, C. G., Hernandez, R. T., Eddine, S. B. Z., & Cai, W. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00626 · Cited by 70
SNPs and Somatic Mutation on Long Non-Coding RNA: New Frontier in the Cancer Studies?
Minotti, L., Agnoletto, C., Baldassari, F., Corrà, F., & Volinia, S. (2018) · Microarrays · doi:10.3390/ht7040034 · Cited by 70
Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
Maier, H. J., Wirth, T., & Beug, H. (2010) · Cancers · doi:10.3390/cancers2042058 · Cited by 71
New insights into pancreatic cancer biology
Hidalgo, M. M. (2012) · Annals of Oncology · doi:10.1093/annonc/mds313 · Cited by 71
PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines
Izetti, P., Hautefeuille, A. H., Abujamra, A. L., de Farias, C. B., Giacomazzi, J., Alemar, B., Lenz, G., Roesler, R., Schwartsmann, G., Osvaldt, A. B., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0090-9 · Cited by 70
Sterol regulatory element-binding protein 1 inhibitors decrease pancreatic cancer cell viability and proliferation
Siqingaowa, Sekar, S., Gopalakrishnan, V., & Taghibiglou, C. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.023 · Cited by 69
Genetics and Genetic Testing in Pancreatic Cancer
Whitcomb, D. C., Shelton, C. A., & Brand, R. E. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.057 · Cited by 69
Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment
Ji, Y. C., Liu, X., Li, J., Xie, X., Huang, M. T.-H., Jiang, J., Liao, Y., Donahue, T. R., & Meng, H. (2020) · Nature Communications · doi:10.1038/s41467-020-17996-7 · Cited by 68
Frequencies and Prognostic Role of KRAS and BRAF Mutations in Patients With Localized Pancreatic and Ampullary Adenocarcinomas
Schultz, N. A., Roslind, A., Christensen, I. J., Horn, T., Høgdall, E., Pedersen, L. N., Kruhøffer, M., Burcharth, F., Wøjdemann, M., & Johansen, J. S. (2012) · Pancreas · doi:10.1097/mpa.0b013e31823cd9df · Cited by 68
Identification of blood‐protein carriers of the CA 19‐9 antigen and characterization of prevalence in pancreatic diseases
Yue, T., Partyka, K. A., Maupin, K. A., Hurley, M. C., Andrews, P., Kaul, K. L., Moser, A. J., Zeh, H. J., Brand, R. E., & Haab, B. B. (2011) · PROTEOMICS · doi:10.1002/pmic.201000827 · Cited by 70
Clinical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma
Kang, C. Y., Wang, J., Axell‐House, D. B., Soni, P., Chu, M., Chipitsyna, G. I., Sarosiek, K., Sendecki, J. A., Hyslop, T., Zoubi, M. S. A., et al. (2013) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2326-y · Cited by 67
MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance
Wang, G., Kang, M., Lu, W., Chen, Y., ZHANG, B., & Wu, Y. (2012) · Oncology Letters · doi:10.3892/ol.2012.784 · Cited by 67
Signaling in the microenvironment of pancreatic cancer: Transmitting along the nerve
Jurcak, N. R., & Zheng, L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.010 · Cited by 67
In vivocharacterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities
Bisht, S., Feldmann, G., Koorstra, J.-B. M., Mullendore, M. E., Alvarez, H., Karikari, C. A., Rudek, M. A., Lee, C. K., Maitra, A., & Maitra, A. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0476 · Cited by 68
Self-citation
Preclinical Safety Evaluation in Rats of a Polymeric Matrix Containing an siRNA Drug Used as a Local and Prolonged Delivery System for Pancreatic Cancer Therapy
Ramot, Y., Rotkopf, S., Gabai, R. M., Zorde Khvalevsky, E., Muravnik, S., Marzoli, G. A., Domb, A. J., Shemi, A., & Nyska, A. (2016) · Toxicologic Pathology · doi:10.1177/0192623316645860 · Cited by 64
Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma
Wartenberg, M., Zlobec, I., Perren, A. A., Koelzer, V. H., Gloor, B., Lugli, A., & Karamitopoulou, E. (2015) · Oncotarget · doi:10.18632/oncotarget.2775 · Cited by 64
Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA‐96
Zhang, Y., Yang, H., Du, Y., Liu, P., Zhang, J., Li, Y., Shen, H., Xing, L., Xue, X., Chen, J., et al. (2019) · Cancer Science · doi:10.1111/cas.14136 · Cited by 66
Interplay between β1-Integrin and Rho Signaling Regulates Differential Scattering and Motility of Pancreatic Cancer Cells by Snail and Slug Proteins
Shields, M. A., Krantz, S. B., Bentrem, D. J., Dangi-Garimella, S. Y., & Munshi, H. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.308940 · Cited by 66
Selective Induction of Apoptosis and Autophagy Through Treatment With Dandelion Root Extract in Human Pancreatic Cancer Cells
Ovadje, P., Chochkeh, M., Akbari-Asl, P., Hamm, C. M., & Pandey, S. (2012) · Pancreas · doi:10.1097/mpa.0b013e31824b22a2 · Cited by 63
Neoplasms of the Exocrine Pancreas
Wolff, R. A., Crane, C. H., Li, D., Evans, D. B., Maitra, A., & Tsai, S. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm094 · Cited by 64
Self-citation
Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas
Ischenko, I., Petrenko, O., & Hayman, M. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319911111 · Cited by 62
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models
Ricci, C., Mota, C., Moscato, S., D’Alessandro, D., Ugel, S., Sartoris, S., Bronte, V., Boggi, U., Campani, D., Funel, N., et al. (2014) · Biomatter · doi:10.4161/21592527.2014.955386 · Cited by 64
A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma
Windon, A. L., Loaiza‐Bonilla, A., Jensen, C. E., Randall, M. P., Morrissette, J. J. D., & Shroff, S. G. (2018) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2017.10.14 · Cited by 61
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis
Chattaragada, M. S., Riganti, C., Sassoé‐Pognetto, M., Principe, M., Santamorena, M. M., Roux, C., Curcio, C., Evangelista, A., Allavena, P., Salvia, R., et al. (2017) · Oncogene · doi:10.1038/onc.2017.358 · Cited by 62
The activating transcription factor 2: an influencer of cancer progression
Huebner, K., Procházka, J., Monteiro, A. C., Mahadevan, V., & Schneider‐Stock, R. (2019) · Mutagenesis · doi:10.1093/mutage/gez041 · Cited by 61
Liquid biopsy in pancreatic cancer: the beginning of a new era
Yadav, D. K., Bai, X., Yadav, R. K., Singh, A., Li, G., Ma, T., Chen, W., & Liang, T. (2018) · Oncotarget · doi:10.18632/oncotarget.24809 · Cited by 62
Demographic, clinical, and pathological features of early onset pancreatic cancer patients
Ntala, C., Debernardi, S., Feakins, R. M., & Crnogorac‐Jurcevic, T. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0866-z · Cited by 60
DIAPH3 promotes pancreatic cancer progression by activating selenoprotein TrxR1‐mediated antioxidant effects
Rong, Y., Gao, J., Kuang, T., Chen, J., Li, J.-A., Huang, Y., Xin, H., Fang, Y., Han, X., Sun, L., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16196 · Cited by 61
Cellular Heterogeneity of Pancreatic Stellate Cells, Mesenchymal Stem Cells, and Cancer-Associated Fibroblasts in Pancreatic Cancer
Sunami, Y., Häußler, J., & Kleeff, J. H. (2020) · Cancers · doi:10.3390/cancers12123770 · Cited by 66
PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression
Lee, Y., Kim, S.-H., Park, H., Park, E. H., Huang, S. M., Jeon, S. B., Kim, J.-M., Lim, D.-S., & Koh, S. S. (2009) · Oncogene · doi:10.1038/onc.2009.298 · Cited by 61
MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinomaviadirect suppression of SMAD2 and SMAD3
Wang, C., Liu, P., Wu, H., Cui, P., Li, Y., Liu, Y., Liu, Z., & Gou, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7482 · Cited by 59
Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential
Knudsen, E. S., Balaji, U., Freinkman, E., McCue, P. A., & Witkiewicz, A. K. (2016) · Oncotarget · doi:10.18632/oncotarget.11893 · Cited by 61
The COL11A1/Akt/CREB signaling axis enables mitochondrial-mediated apoptotic evasion to promote chemoresistance in pancreatic cancer cells through modulating BAX/BCL-2 function
Wang, H., Ren, R., Yang, Z., Cai, J., Du, S., & Shen, X. (2021) · Journal of Cancer · doi:10.7150/jca.47032 · Cited by 57
Molecular Characteristics of Pancreatic Ductal Adenocarcinoma
Ottenhof, N. A., de Wilde, R. F., Maitra, A., Hruban, R. H., & Offerhaus, G. J. A. (2011) · Pathology Research International · doi:10.4061/2011/620601 · Cited by 62
Self-citation
BET inhibitors block pancreatic stellate cell collagen I production and attenuate fibrosis in vivo
Kumar, K., DeCant, B. T., Grippo, P. J., Hwang, R. F., Bentrem, D. J., Ebine, K., & Munshi, H. G. (2017) · JCI Insight · doi:10.1172/jci.insight.88032 · Cited by 57
Myeloid Cell Mediated Immune Suppression in Pancreatic Cancer
Kemp, S. B., di Magliano, M. P., & Crawford, H. C. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.07.006 · Cited by 64
Transcriptional regulation of fibronectin by p21-activated kinase-1 modulates pancreatic tumorigenesis
Jagadeeshan, S., Krishnamoorthy, Y. R., Singhal, M., Subramanian, A., Mavuluri, J., Lakshmi, A., Roshini, A., Baskar, G., Ravi, M., Joseph, L., et al. (2014) · Oncogene · doi:10.1038/onc.2013.576 · Cited by 57
Snail Cooperates with KrasG12D to Promote Pancreatic Fibrosis
Shields, M. A., Ebine, K., Sahai, V., Kumar, K., Siddiqui, K., Hwang, R. F., Grippo, P. J., & Munshi, H. G. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0637 · Cited by 59
Ras Activity in Acinar Cells Links Chronic Pancreatitis and Pancreatic Cancer
Logsdon, C. D., & Ji, B. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.07.040 · Cited by 57
HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter
Yang, J., Zhu, D., Zhou, X., Yin, N., Zhang, Y., Zhang, Z., Li, D., & Zhou, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17999 · Cited by 56
Revisiting the tumorigenesis timeline with a data-driven generative model
Lahouel, K., Laurent Younes, B., Danilova, L., Giardiello, F. M., Hruban, R. H., Groopman, J. D., Kinzler, K. W., Vogelstein, B., Geman, D., & Tomasetti, C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914589117 · Cited by 56
Self-citation
Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells
Li, M., Yu, X., Guo, H., Sun, L., Wang, A., Liu, Q., Wang, X., & Li, J. (2013) · Tumor Biology · doi:10.1007/s13277-013-1326-6 · Cited by 54
Vascular Invasion in Infiltrating Ductal Adenocarcinoma of the Pancreas Can Mimic Pancreatic Intraepithelial Neoplasia
Hong, S., Goggins, M., Wolfgang, C. L., Schulick, R. D., Edil, B. H., Cameron, J. L., Handra‐Luca, A., Herman, J. M., & Hruban, R. H. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182376e36 · Cited by 54
Self-citation
Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages
Sushil Kumar, K., Torres, M. P., Kaur, S., Rachagani, S., Joshi, S., Johansson, S. L., Momi, N., Baine, M. J., Gilling, C. E., Smith, L. M., et al. (2014) · Oncogene · doi:10.1038/onc.2014.154 · Cited by 54
Cancer-Associated Fibroblasts’ Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma
Awaji, M. I., & Singh, R. K. (2019) · Cancers · doi:10.3390/cancers11030290 · Cited by 55
A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells
Sempere, L. F., Gunn, J. R., & Korc, M. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.3.15979 · Cited by 53
Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer
Kumar, K., Chow, C. R., Ebine, K., Arslan, A. D., Kwok, B., Bentrem, D. J., Eckerdt, F., Platanias, L. C., & Munshi, H. G. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0285 · Cited by 52
Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway
Chen, S., Kuo, T., Liao, Y.-Y., Lin, M., Tien, Y., & Huang, M. (2018) · Oncogene · doi:10.1038/s41388-018-0403-0 · Cited by 52
Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
Tong, Y., Sun, M., Chen, L., Wang, Y., Yan, L., Li, L., Zhang, X., Cai, Y., Qie, J., Pang, Y., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01384-3 · Cited by 52
Calmodulin Mediates Fas-induced FADD-independent Survival Signaling in Pancreatic Cancer Cells via Activation of Src-Extracellular Signal-regulated Kinase (ERK)
Yuan, K., Gu, J., Chen, J., Liu, H., Zhang, K., Li, Y., Wu, H., McDonald, J. M., & Chen, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.202804 · Cited by 51
Pancreatic cancer organotypic cultures
Froeling, F. E. M., Marshall, J. F., & Kocher, H. M. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.008 · Cited by 51
IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation
Garcia, M. N., Grasso, D., López‐Millán, B., Hamidi, T., Loncle, C., Tomasini, R., Lomberk, G. A., Porteu, F., Urrutia, R. A., & Iovanna, J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76037 · Cited by 51
Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer
Rajeshkumar, N. V., Yabuuchi, S., Pai, S. G., Tong, Z., Hou, S., Bateman, S., Pierce, D. W., Heise, C. C., Hoff, D. D. V., Maitra, A., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.215 · Cited by 51
Self-citation
The ROS-KRAS-Nrf2 axis in the control of the redox homeostasis and the intersection with survival-apoptosis pathways: Implications for photodynamic therapy
Ferino, A., Rapozzi, V., & Xodo, L. E. (2019) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2019.111672 · Cited by 51

Authors: Maitra, A., & Hruban, R. H.
Affiliations: Johns Hopkins University (US)
ORCID: Maitra, Anirban
Hruban, Ralph H.
Venue: Annual Review of Pathology: Mechanisms of Disease
Publisher: Annual Reviews
Published: 2008-02-01
Volume: 3
Issue: 1
Pages: 157-188
ISSN: 1553-4006 (ISSN-L)
1553-4014
DOI: 10.1146/annurev.pathmechdis.3.121806.154305
PMC: PMC2666336
OpenAlex: W4211122150
Cited by: 707
References: 185
Citations by year: 2026: 16 · 2025: 10 · 2024: 31 · 2023: 29 · 2022: 55 · 2021: 46 · 2020: 46 · 2019: 39 · 2018: 43 · 2017: 42 · 2016: 41 · 2015: 53 · 2014: 59 · 2013: 48 · 2012: 32
FWCI: 3.60
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Annual Review of Pathology Mechanisms of Disease (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (R01CA113669, P50CA062924)
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
Keywords: pancreatic cancer, germline mutations, somatic mutations, KRAS2, CDKN2A, TP53, genetic alterations, transcriptomic alterations, cell cycle dysregulation, metastasis, precursor lesions, genetically engineered mouse models, tumor progression, cancer stem cells, treatment resistance
MeSH terms: Animals, Disease Models, Animal, Humans, Pancreatic Neoplasms, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pancreatic Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks